Organizations should focus just as much of their attention on securing the actual medical devices they produce as the network they depend on, writes Chris Souza.
Almost a year and a half later, key understandings have emerged to help companies better combat future data-breach attempts.
One year after the Merck cyber attack pharma takes stock of what the industry has learned and what to do moving forward.